Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.555
Delayed Data
As of May 24
 -0.0067 / -1.19%
Today’s Change
0.51
Today|||52-Week Range
2.48
-57.95%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close0.56
Today’s open0.56
Day’s range0.56 - 0.60
Volume210,584
Average volume (3 months)149,092
Market cap$16.9M
Dividend yield--
Data as of 3:59pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)-8.57%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
NVUSNovus Therapeutics I...-0.09-1.61%
KTOVKitov Pharmaceutical...+0.08+4.78%
MBRXMoleculin Biotech In...+0.07+8.08%
SBOTStellar Biotechnolog...-0.03-2.36%
Data as of 3:59pm ET, 05/24/2017

Financials

Next reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$17.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Larry M. Dillaha
CFO, Secretary &
Principal Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts